Hemodynamic Support Devices

This hemodynamic support systems include intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or tandemheart, and ventricular assist devices (VAD).

Abiomed Receives FDA PMA Approval for Impella 5.5 With SmartAssist
Technology | Ventricular Assist Devices (VAD) | September 27, 2019

September 27, 2019 — Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug...

Videos | Hemodynamic Support Devices | September 22, 2019

There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the...

CorWave Presents First Successful In Vivo 60-day Study of Neptune LVAD
News | Ventricular Assist Devices (VAD) | September 12, 2019

September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its...

Experts Caution Against Catch-all Assumptions About LVADs and Mitral Regurgitation

Paul Tang, M.D., Ph.D., a cardiac surgeon at Michigan Medicine’s Frankel Cardiovascular Center in the OR. Image courtesy of Michigan Medicine.

News | Ventricular Assist Devices (VAD) | August 20, 2019

August 20, 2019 — Left...

In July, the biggest news item was Datascope initiating a Class I recalled of its intra-aortic balloon pumps due to potential battery failure.  Most Popular Cardiology Technology Content in July 2019

In July, the biggest news item was Datascope initiating a Class I recalled of its intra-aortic balloon pumps due to potential battery failure. 

 

Feature | August 02, 2019 | Dave Fornell, Editor

August 2, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC...

Procyrion Receives FDA Breakthrough Device Designation for Aortix System
Technology | Heart Failure | July 30, 2019

July 30, 2019 – Procyrion Inc. secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA...

Datascope Recalls Intra-Aortic Balloon Pumps Due to Potential Battery Failure. FDA Class I recall includes the Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i IABP.
Feature | Intra-Aortic Balloon Pumps (IABP) | July 24, 2019

July 24, 2019 — The U.S. Food and Drug Administration announced Maquet/Datascope is recalling all...

FDA Confirms Impella RP is Safe and Effective
News | Ventricular Assist Devices (VAD) | June 12, 2019

June 12, 2019 — In a letter sent to healthcare providers, the U.S. Food and Drug Administration (FDA) validates that...

Impella SmartAssist Platform Launches at SCAI
News | Ventricular Assist Devices (VAD) | May 22, 2019

May 22, 2019 — Abiomed announced that the Impella CP with SmartAssist will be commercially available beginning at...

SCAI Releases New Consensus Document on Classification Stages of Cardiogenic Shock

Image courtesy of the Society for Cardiovascular Angiography and Interventions (SCAI).

News | Cardiogenic Shock | May 20, 2019

May 20, 2019 – A newly released expert consensus statement proposes a classification schema for...

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use
Technology | Ventricular Assist Devices (VAD) | May 14, 2019

May 14, 2019 — The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and...

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial
News | Ventricular Assist Devices (VAD) | May 02, 2019

May 2, 2019 — Abiomed announced that, on April 26, the U.S. Food and Drug Administration (FDA) approved initiation...

Overlay Init